Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ran Weissman"'
Autor:
Justin Buthorn, Noam Shomron, Fleur Cohen, Jean-François Emile, Roei D Mazor, Ofer Shpilberg, Omar Abdel-Wahab, Zahir Amoura, Eli L. Diamond, Ran Weissman, Benjamin H. Durham, Julien Haroche, Oshrat Hershkovitz-Rokah
Publikováno v:
Leukemia
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2021, ⟨10.1038/s41375-021-01472-2⟩
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2021, ⟨10.1038/s41375-021-01472-2⟩
Erdheim–Chester disease (ECD) is characterized by excessive production and accumulation of histiocytes within multiple tissues and organs. ECD patients harbor recurrent mutations of genes associated with the RAS/RAF/MEK/ERK signaling pathway, parti
Autor:
Helena Tuchinsky, Eti Zigman-Hoffman, Gary Gellerman, Ran Weissman, Andrii Bazylevich, Oshrat Hershkovitz-Rokah, Ofer Shpilberg, Leonid D. Patsenker
Publikováno v:
Medicinal Chemistry. 15:537-549
Background: Scientists have extensively investigated curcumin, yielding many publications on treatments of cancer. Numerous derivatives of curcumin were synthesized, evaluated for their anti-oxidant and free-radical scavenging, SAR, ADME properties a
Autor:
Ran Weissman, Omar Abdel-Wahab, Ofer Shpilberg, Shirley Shapira, Judith Luckman, Eli L. Diamond, Roei D Mazor, Liran Domachevsky, Oshrat Hershkovitz-Rokah, David Groshar
Publikováno v:
Neuro-oncology Advances
Background Erdheim–Chester disease (ECD), a rare inflammatory myeloid neoplasm, is known to be fundamentally reliant on the constitutive activation of the MAPK signaling pathway in the majority of patients. Consequently, inhibition of the V600E-mut
Autor:
Nir Pillar, Galia Stemer, Eli L. Diamond, Benjamin H. Durham, Ofer Shpilberg, Omar Abdel-Wahab, Zahir Amoura, Ran Weissman, Jean-François Emile, Julien Haroche, Fleur Cohen, Justin Buthorn, Michelle Ki, Gary A. Ulaner, Oshrat Hershkovitz-Rokah, Guy Shapira, Noam Shomron, Roei D Mazor
Publikováno v:
Cancers
Cancers, MDPI, 2020, 12 (11), pp.1-20. ⟨10.3390/cancers12113240⟩
Volume 12
Issue 11
Cancers, Vol 12, Iss 3240, p 3240 (2020)
Cancers, MDPI, 2020, 12 (11), pp.1-20. ⟨10.3390/cancers12113240⟩
Volume 12
Issue 11
Cancers, Vol 12, Iss 3240, p 3240 (2020)
The pathogenesis of histiocytic neoplasms is driven by mutations activating the MAPK/ERK pathway, but little is known about the transcriptional and post-transcriptional alterations involved in these neoplasms. We analyzed microRNA (miRNA) expression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da2377320e7004ec40620f441afabf4d
https://hal.archives-ouvertes.fr/hal-03032298
https://hal.archives-ouvertes.fr/hal-03032298
Autor:
Michelle Ki, Ofer Shpilberg, Oshrat Hershkovitz Rokah, Omar Abdel-Wahab, Roei D Mazor, Nir Pilar, Benjamin H. Durham, Ran Weissman, Eli L. Diamond, Noam Shomron
Publikováno v:
Blood. 132:2397-2397
Background: Erdheim-Chester disease (ECD) is a rare hematological malignancy, belonging to the L-group histiocytoses. ECD is characterized by multi-systemic proliferations of mature histiocytes in a background of inflammatory stroma. The inflammatory